Havix Group Inc d/b/a Aavis Pharmaceuticals

FDA inspection history in Hoschton, Georgia, 2022

1
Form 483

Every document, by year

  • Form 483

2022: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2022One Form 483, at Hoschton, Georgia.

Cited most

Across all Havix Group Inc d/b/a Aavis Pharmaceuticals observations on file

The complete Havix Group Inc d/b/a Aavis Pharmaceuticals file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2022-04-19483 Form 483$99

Investigators on these documents

Gretchen M. Laws (1)Susan O. Oladeji (1)

FEI number 3012841169 · most recent document Apr 19, 2022

About Havix Group Inc d/b/a Aavis Pharmaceuticals

How many FDA Form 483s has Havix Group Inc d/b/a Aavis Pharmaceuticals received?

FDA Intel has 1 Form 483 on file for Havix Group Inc d/b/a Aavis Pharmaceuticals; the most recent is dated Apr 19, 2022.

When was Havix Group Inc d/b/a Aavis Pharmaceuticals last inspected by FDA?

The most recent FDA inspection document on file for Havix Group Inc d/b/a Aavis Pharmaceuticals is a Form 483 dated Apr 19, 2022, for the site in Hoschton, Georgia.

What did FDA cite at Havix Group Inc d/b/a Aavis Pharmaceuticals?

The regulations cited most in the observations on file for Havix Group Inc d/b/a Aavis Pharmaceuticals are 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.67 (Equipment cleaning and maintenance), 1 time; 21 CFR 211.68 (Automatic, mechanical, and electronic equipment), 1 time.